Pharmeasy, Curefoods & Eeki Foods

Pharmeasy Leads As Indian Startups Raise $377 Mn In Weekly Funding

Soumya Verma
2 Min Read

Summary:

  •  Over 25 deals closed this week, totaling $377 Mn in fresh capital
  •  Pharmeasy leads with $216 Mn, followed by Curefoods’ $36 Mn
  •  Healthtech, foodtech, and agritech sectors drive investor confidence

Pharmeasy Dominates With $216 Mn Mega Round

This week, Indian startups raised an impressive $377 million across 25+ deals, reflecting resilience in the ecosystem despite tighter global capital flows.

Leading the charge was healthtech unicorn Pharmeasy, which bagged $216 Mn through a rights issue. The fresh funds are expected to help the company reduce debt, stabilize operations, and fuel its long-term healthcare platform ambitions. The deal marks one of the largest raises in India’s healthtech sector this year.

Curefoods, Eeki Foods & Consumer Brands Add Momentum

Curefoods, the cloud kitchen operator founded by Ankit Nagori, secured $36 Mn from a clutch of investors including Three State Ventures and Spring Marketing Capital. The startup plans to expand its multi-brand food portfolio and deepen its offline footprint across Tier I and II cities.

Meanwhile, agritech innovator Eeki Foods raised $16 Mn to scale its farm automation and climate-resilient agriculture technology. The week also saw a steady flow of early-stage deals in consumer brands, SaaS, and fintech, with ticket sizes ranging from $3 Mn to $10 Mn.

Sector Snapshot: Healthtech, Foodtech, Agritech In Spotlight

  • Healthtech: Pharmeasy’s mega round reaffirms investor confidence in digital healthcare.
  • Foodtech: Curefoods’ fresh raise signals sustained appetite for cloud kitchens and D2C food brands.
  • Agritech: Eeki Foods highlights how climate-focused innovation is pulling capital.
  • SaaS & Fintech: Early-stage startups continue to attract steady funding, pointing to long-term scalability.
Share This Article

Don’t Miss Startup News That Matters

Join thousands of readers getting daily startup stories, funding alerts, and industry insights.

Newsletter Form

Free forever. No spam.